Kymera Therapeutics to Report Second Quarter 2025 Financial Results on August 11, 2025
Provided By GlobeNewswire
Last update: Aug 4, 2025
WATERTOWN, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, will report second quarter 2025 financial results on August 11, 2025. The Company will host a video conference call and webcast at 8:30 a.m. ET that day.
Read more at globenewswire.com
